Q3 2020 Holdings
Filed 2020-11-16 | 43 holdings | $81.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $22.9M | 1,545,000 | 28.0% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $13.6M | 390,000 | 16.7% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $12.2M | 1,646,700 | 14.9% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $9.1M | 688,000 | 11.1% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $7.7M | 357,500 | 9.5% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $4.4M | 101,500 | 5.3% |
| Cardiff Oncology Inc(CRDF) | COM | 14147L108 | $4.3M | 305,900 | 5.3% |
| Annexon Inc(ANNX) | COM | 03589W102 | $3.3M | 110,000 | 4.1% |
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $2.3M | 660,000 | 2.8% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $1.6M | 22,500 | 2.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $43.5K | 511,500 | 0.1% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $29.8K | 973,000 | 0.0% |
| Spdr SER TR(XBI)Put | S&P BIOTECH | 78464A870 | $27.9K | 250,000 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $13.8K | 225,000 | 0.0% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $12.6K | 830,000 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $12.4K | 667,500 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $12.1K | 853,000 | 0.0% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $10.7K | 417,500 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $10.4K | 277,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $10.4K | 315,000 | 0.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $8.8K | 250,000 | 0.0% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $7.7K | 240,000 | 0.0% |
| Lifesci Acquisition Corp | UNIT 03/31/2025 | 53228P208 | $7.6K | 560,000 | 0.0% |
| Surface Oncology Inc | COM | 86877M209 | $7.5K | 1,088,000 | 0.0% |
| Athira Pharma Inc | COM | 04746L104 | $6.7K | 362,500 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $6.6K | 235,000 | 0.0% |
| Catalyst Biosciences Inc | COM NEW | 14888D208 | $6.4K | 1,497,900 | 0.0% |
| Selecta Biosciences Inc(SELBUSD) | COM | 816212104 | $5.9K | 2,364,204 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $5.5K | 765,000 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $5.0K | 167,054 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $4.5K | 802,500 | 0.0% |
| Health Sciences ACQ Corp 2 | ORD SHS | G4411D109 | $4.3K | 392,500 | 0.0% |
| Avadel Pharmaceuticals PLC | SPONSORED ADR | 05337M104 | $3.6K | 705,218 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $3.6K | 240,744 | 0.0% |
| Panacea Acquisition Corp | UNIT 99/99/9999 | 698102209 | $3.4K | 280,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $3.3K | 300,000 | 0.0% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $3.0K | 381,500 | 0.0% |
| Concert Pharmaceuticals Inc(CNCEEUR) | COM | 206022105 | $2.9K | 300,000 | 0.0% |
| Verastem Inc | COM | 92337C104 | $2.9K | 2,400,000 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $1.0K | 13,500 | 0.0% |
| Unum Therapeutics Inc | COM | 903214104 | $959 | 410,000 | 0.0% |
| Clearside Biomedical Inc(CLSDUSD) | COM | 185063104 | $947 | 615,000 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $913 | 107,500 | 0.0% |